ARTA
CNSY

A.R.T. Advisors’s Cerenome, Inc. Common Stock CNSY Stock Holding History

A.R.T. Advisors’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-32
Closed -$41K – 1635
2019
Q3 		$41K Buy
+32
New +$116K ﹤0.01% 1332

Other funds holding CNSY

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

A.R.T. Advisors's CNSY Position: Q4 2019 in Review

A.R.T. Advisors sold out of Cerenome, Inc. Common Stock (CNSY) in Q4 2019, closing a stake of 32 shares — an estimated $41K sold.

A.R.T. Advisors first reported a position in CNSY in Q3 2019 and held it in 1 quarter. The position peaked at $41K in Q3 2019. 9 funds tracked by Wall St. Rank hold CNSY as of Q4 2019.

  • A.R.T. Advisors reported no remaining Cerenome, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 32 Cerenome, Inc. Common Stock shares in Q4 2019, an estimated $41K.
  • A.R.T. Advisors first reported a position in Cerenome, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • A.R.T. Advisors's Cerenome, Inc. Common Stock position peaked at $41K in Q3 2019.
  • 9 funds tracked by Wall St. Rank held Cerenome, Inc. Common Stock as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.